BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang C, Lian H, Xie L, Yin N, Cui Y. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p. Biol Chem 2020;401:1053-61. [PMID: 32229685 DOI: 10.1515/hsz-2019-0430] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang B, Wang X, Li P, Niu X, Liang X, Liu G, Liu Z, Ge H. Osteosarcoma Cell-Derived Exosomal ELFN1-AS1 Mediates Macrophage M2 Polarization via Sponging miR-138-5p and miR-1291 to Promote the Tumorgenesis of Osteosarcoma. Front Oncol 2022;12:881022. [DOI: 10.3389/fonc.2022.881022] [Reference Citation Analysis]
2 Jing X, Du L, Shi S, Niu A, Wu J, Wang Y, Wang C. Hypoxia-Induced Upregulation of lncRNA ELFN1-AS1 Promotes Colon Cancer Growth and Metastasis Through Targeting TRIM14 via Sponging miR-191-5p. Front Pharmacol 2022;13:806682. [PMID: 35652045 DOI: 10.3389/fphar.2022.806682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cao L, Ma X, Rong P, Zhang J, Yang M, Wang W, Mi Y. Comprehensive Analysis of DNA Methylation and Transcriptome to Identify PD-1-Negative Prognostic Methylated Signature in Endometrial Carcinoma. Disease Markers 2022;2022:1-24. [DOI: 10.1155/2022/3085289] [Reference Citation Analysis]
4 Zhuang SH, Meng CC, Fu JJ, Huang J. Long non-coding RNA ELFN1-AS1-mediated ZBTB16 inhibition augments the progression of gastric cancer by activating the PI3K/AKT axis. Kaohsiung J Med Sci 2022. [PMID: 35451560 DOI: 10.1002/kjm2.12548] [Reference Citation Analysis]
5 Cheng J, Yang Q, Han X, Wang H, Wu K, Zhao H. Yin Yang 1-stimulated long noncoding RNA bladder cancer-associated transcript 1 upregulation facilitates esophageal carcinoma progression via the microRNA-5590-3p/programmed cell death-ligand 1 pathway. Bioengineered 2022;13:10244-57. [DOI: 10.1080/21655979.2022.2061303] [Reference Citation Analysis]
6 He Y, Zhou H, Xu H, You H, Cheng H. Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients. Front Oncol 2022;12:769202. [DOI: 10.3389/fonc.2022.769202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yang B, Miao S. lncRNA ELFN1-AS1 predicts poor prognosis and promotes tumor progression of non-small cell lung cancer by sponging miR-497. CBM 2022. [DOI: 10.3233/cbm-210393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wang J, Li C, Hou P. Feature screening for survival trait with application to TCGA high-dimensional genomic data. PeerJ 2022;10:e13098. [DOI: 10.7717/peerj.13098] [Reference Citation Analysis]
9 Zhao S, Jiang H, Liu J, Li D, Li B, Long Q, Zheng L, Gu H, Wang F. Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/5994800] [Reference Citation Analysis]
10 Ketzer F, Abdelrasoul H, Vogel M, Marienfeld R, Müschen M, Jumaa H, Wirth T, Ushmorov A. CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia. Oncogenesis 2022;11:1. [PMID: 35013097 DOI: 10.1038/s41389-021-00377-0] [Reference Citation Analysis]
11 Jie Y, Ye L, Chen H, Yu X, Cai L, He W, Fu Y. ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer. Bioengineered 2020;11:872-82. [PMID: 32779991 DOI: 10.1080/21655979.2020.1797281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
12 Ma G, Li G, Gou A, Xiao Z, Xu Y, Song S, Guo K, Liu Z. Long non-coding RNA ELFN1-AS1 in the pathogenesis of pancreatic cancer. Ann Transl Med 2021;9:877. [PMID: 34164511 DOI: 10.21037/atm-21-2376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhang T, Li W, Gu M, Wang Z, Zhou S, Hao X, Li W, Xu S. Clinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation. Cancer Manag Res 2021;13:3539-50. [PMID: 33953608 DOI: 10.2147/CMAR.S305179] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Du Y, Hou Y, Shi Y, Liu J, Li T. Long Non-Coding RNA ELFN1-AS1 Promoted Colon Cancer Cell Growth and Migration via the miR-191-5p/Special AT-Rich Sequence-Binding Protein 1 Axis. Front Oncol 2020;10:588360. [PMID: 33634016 DOI: 10.3389/fonc.2020.588360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
15 Feng W, Zhu R, Ma J, Song H. LncRNA ELFN1-AS1 Promotes Retinoblastoma Growth and Invasion via Regulating miR-4270/SBK1 Axis. Cancer Manag Res 2021;13:1067-73. [PMID: 33574704 DOI: 10.2147/CMAR.S281536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Guo J, Gan Q, Gan C, Zhang X, Ma X, Dong M. LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis. Aging (Albany NY) 2021;13:5297-311. [PMID: 33535182 DOI: 10.18632/aging.202450] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
17 Kang H, Wang N, Wang X, Zhang Y, Lin S, Mao G, Liu D, Dang C, Zhou Z. A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma. Aging (Albany NY) 2020;12:25828-44. [PMID: 33234735 DOI: 10.18632/aging.104206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
18 Wang G, Xu G, Wang W. Long Noncoding RNA CDKN2B-AS1 Facilitates Lung Cancer Development Through Regulating miR-378b/NR2C2. Onco Targets Ther 2020;13:10641-9. [PMID: 33116641 DOI: 10.2147/OTT.S261973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
19 Shen X, Li Y, He F, Kong J. LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma via Sponging miR-424-5p. Cancer Manag Res 2020;12:6807-19. [PMID: 32801906 DOI: 10.2147/CMAR.S240000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
20 Zhou SN. Role of non-coding RNAs in esophageal carcinoma. Shijie Huaren Xiaohua Zazhi 2020; 28(12): 453-459 [DOI: 10.11569/wcjd.v28.i12.453] [Reference Citation Analysis]